Explore
13D/13G Activist Filings
118,703 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | HNST | The Honest Company, Inc. | Jessica Warren | 13G/A | 5.4% | 0 |
| Feb 18, 2026 | CNTB | Connect Biopharma Holdings Ltd | Zheng Wei | 13G/A | 9.0% | 5.0M |
| Feb 18, 2026 | N/A | Silicon Valley Acquisition Corp. | Silicon Valley Acquisition Sponsor LLC | 13D/A | 25.9% | 7.6M |
| Feb 18, 2026 | AFIB | Acutus Medical, Inc. | Advent Life Sciences LLP | 13G/A | 0.0% | 0 |
| Feb 18, 2026 | AURA | Aura Biosciences, Inc. | Advent Life Sciences LLP | 13G/A | 3.3% | 2.0M |
| Feb 18, 2026 | BBIO | BridgeBio Pharma, Inc. | VIKING GLOBAL INVESTORS LP | 13D/A | 6.8% | 13.0M |
| Feb 18, 2026 | DCBO | Docebo Inc. | Jason Chapnik | 13D | 56.7% | 16.3M |
| Feb 18, 2026 | GOOGL | Alphabet Inc. | Sergey Brin | 13G/A | 5.8% | 359.4M |
| Feb 18, 2026 | IHS | IHS Holding Limited | International Finance Corporation | 13G | 5.7% | 19.2M |
| Feb 18, 2026 | ARES | Ares Management Corporation | Antony P. Ressler | 13G/A | 34.2% | 111.7M |
| Feb 18, 2026 | ARES | Ares Management Corporation | Ares Partners Holdco LLC | 13G/A | 33.4% | 109.4M |
| Feb 18, 2026 | AEMD | AETHLON MEDICAL INC | Alumni Capital LP | 13G/A | 4.0% | 56K |
| Feb 18, 2026 | OVID | Ovid Therapeutics Inc. | ADAR1 Capital Management, LLC | 13G | 6.9% | 9.3M |
| Feb 18, 2026 | SPRB | Spruce Biosciences, Inc. | ADAR1 Capital Management, LLC | 13G | 5.4% | 58K |
| Feb 18, 2026 | OKUR | OnKure Therapeutics, Inc. | ADAR1 Capital Management, LLC | 13G | 7.9% | 1.0M |
| Feb 18, 2026 | BNZI | Banzai International, Inc. | CP BF Lending, LLC | 13G | 18.7% | 2.7M |
| Feb 18, 2026 | KLRS | KALARIS THERAPEUTICS, INC. | Samsara BioCapital, L.P. | 13D/A | 47.9% | 11.0M |
| Feb 18, 2026 | QNRX | Quoin Pharmaceuticals, Ltd. | ADAR1 Capital Management, LLC | 13G | 6.9% | 58K |
| Feb 18, 2026 | ADGM | Adagio Medical Holdings, Inc. | ADAR1 Capital Management, LLC | 13G | 5.7% | 1.2M |
| Feb 18, 2026 | BOLT | Bolt Biotherapeutics, Inc. | Nan Fung Group Holdings Limited | 13D/A | 6.7% | 128K |
| Feb 18, 2026 | NYT | The New York Times Company | Darsana Capital Partners LP | 13G/A | 4.7% | 7.7M |
| Feb 18, 2026 | N/A | Grupo Aeromexico, S.A.B. de C.V. | Silver Point Capital, L.P. | 13G | 9.0% | 131.7M |
| Feb 18, 2026 | NAVN | NAVAN, INC. | Ilan Twig | 13G | 5.3% | 13.0M |
| Feb 18, 2026 | SATS | EchoStar CORP | Darsana Capital Partners LP | 13G/A | 4.5% | 7.0M |
| Feb 18, 2026 | GDS | GDS Holdings Limited | GIC Private Limited | 13G/A | 11.3% | 198.2M |
| Feb 18, 2026 | RLJ-PA | RLJ Lodging Trust | Infrastructure Capital Advisors, LLC | 13G/A | 0.0% | 0 |
| Feb 18, 2026 | GENI | Genius Sports Limited | NFL Enterprises LLC | 13G/A | 6.4% | 15.3M |
| Feb 18, 2026 | N/A | Prime Meridian Holding Co | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 18, 2026 | FLG-PU | New York Community Capital Trust V | Infrastructure Capital Advisors, LLC | 13G/A | 0.0% | 0 |
| Feb 18, 2026 | LUNR | Intuitive Machines, Inc. | Stephen Altemus | 13G/A | 9.8% | 12.8M |
| Feb 18, 2026 | LUNR | Intuitive Machines, Inc. | Timothy Crain | 13G/A | 7.1% | 9.1M |
| Feb 18, 2026 | EVMN | EVOMMUNE, INC. | RA Capital Management, L.P. | 13D/A | 9.7% | 3.5M |
| Feb 18, 2026 | N/A | SPYGLASS PHARMA, INC. | Samsara BioCapital, L.P. | 13G | 4.5% | 1.5M |
| Feb 18, 2026 | N/A | SPYGLASS PHARMA, INC. | RA Capital Management, L.P. | 13D | 24.1% | 8.0M |
| Feb 18, 2026 | GLTO | Galecto, Inc. | Venrock Healthcare Capital Partners III, L.P. | 13G | 6.0% | 3.6M |
| Feb 18, 2026 | NVRI | ENVIRI Corp | Fund 1 Investments, LLC | 13G/A | 5.3% | 4.3M |
| Feb 18, 2026 | FLWS | 1 800 FLOWERS COM INC | Fund 1 Investments, LLC | 13G/A | 14.6% | 5.4M |
| Feb 18, 2026 | N/A | Private Bancorp of America, Inc. | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 18, 2026 | NAVN | NAVAN, INC. | Lightspeed Venture Partners X, L.P. | 13G | 10.0% | 23.4M |
| Feb 18, 2026 | RBRK | RUBRIK, INC. | Lightspeed Venture Partners IX, L.P. | 13G/A | 2.6% | 4.2M |
| Feb 18, 2026 | NUAI | New ERA Energy & Digital, Inc. | Zhou Zachary Yi | 13G/A | 9.9% | 5.3M |
| Feb 18, 2026 | CXH | MFS INVESTMENT GRADE MUNICIPAL TRUST | Almitas Capital LLC | 13G | 5.5% | 789K |
| Feb 18, 2026 | N/A | Community Heritage Financial, Inc. | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | VOR | VOR BIOPHARMA INC. | Verve Capital Limited | 13G/A | 9.9% | 4.3M |
| Feb 17, 2026 | DJCO | Daily Journal Corporation | RWWM, Inc. | 13G/A | 25.5% | 352K |
| Feb 17, 2026 | CMU | MFS HIGH YIELD MUNICIPAL TRUST | Almitas Capital LLC | 13G | 5.9% | 2.2M |
| Feb 17, 2026 | FDMT | 4D MOLECULAR THERAPEUTICS, INC. | Novo Holdings A/S | 13G/A | 6.4% | 3.7M |
| Feb 17, 2026 | ANTX | AN2 Therapeutics, Inc. | Almitas Capital LLC | 13G | 5.4% | 3.0M |
| Feb 17, 2026 | EVO | Evotec SE | Novo Holdings A/S | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | KYTX | Kyverna Therapeutics, Inc. | Northpond Ventures III, LP | 13G/A | 4.9% | 2.8M |